Skip to content
Est. 1998 proudly celebrating our 27th year of championing American business
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

ARTELO BIOSCIENCES, INC.

  • SOLANA BEACH, California
  • Public · NASDAQ: ARTL
  • 7 employees
$4.8MMarket cap
-$12.9MNet income
7Employees
ARTLNASDAQ
2015IPO

About ARTELO BIOSCIENCES, INC.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Net income
-$12.9M
Total assets
$2.8M
Market cap
$4.8M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: ARTL

15-minute delayed · data by Polygon.io

Market cap
$4.8M
Open
Day range
Prev close
Volume
IPO date
Oct 13, 2015

Market data by Polygon.io · prices are 15-minute delayed

No reviews yet. Be the first to review ARTELO BIOSCIENCES, INC..

Write a review
Explore

Similar companies

Browse all →